Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]
Roche is also close to completing enrolment of a global randomised, double-blind, placebo-controlled phase III clinical trial of Actemra®/RoActemra® (tocilizumab) in hospitalised patients with severe […]
The impact of the COVID-19 pandemic is not gender neutral, as it affects men and women differently. Therefore, we must not be gender blind in […]
Copyright © 2021 | WordPress Theme by MH Themes
